Series: Industry 101
Despite expansive growth in pediatric dermatology, the number of board-certified pediatric dermatologists remains devastatingly small. The number of pediatric dermatologists conducting research is even smaller, and the number with comfort partnering with industry or participating in clinical trials is smaller still.
To address this issue, PeDRA created Industry 101, a 5-part podcast series of expert-led discussions presenting perspectives from industry partners, PeDRA members, and leaders on how to better understand industry and facilitate meaningful engagement between academic clinician-scientists and industry partners. Hosted by Harper Price, MD, experts will discuss a variety of topics from clinical trials and investigator-initiated studies to conflicts of interest and strategies for working with large and small companies.
This new series kicks off with Episode 1: Intro to Industry with the series’ chair, Harper Price, MD. Discover how Dr. Price’s creative energy and passion for helping patients are the reasons she partners with industry and leads clinical trials. The episode wraps up with questions from a live studio audience and a preview of what’s ahead in the Industry 101 series.
Episode 2: Clinical Trials – Listen to Dr. Harper Price and Dr. Lee Zane discuss Dr. Zane’s unique experience in academic research as well as pharma. Dr. Zane shares his insights on everything from the keys to designing a good clinical trial to forming research questions that are valuable to achieving both clinical and industry regulatory goals.
Podcast Series
Harper Price, MD
Program Chair and Host
Division Chief, Pediatric Dermatology
Phoenix Children’s Hospital
Lee Zane, MD, MAS
Guest Speaker
Former Assistant Professor of Clinical Dermatology and Epidemiology/Biostatistics at the University of California, San Fransisco, and Former Vice President and Chief Medical Officer at Anacor Pharmaceuticals
Special thanks to Arcutis Biotherapeutics, Dermavant Sciences, Galderma, Incyte, and Sanofi Genzyme and Regeneron Pharmaceuticals for their support of this independent medical education program. PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.